Impatience: Inpatient Endoscopy Procedure Planning Delays and Impact on Length of Stay and 30-day Readmission

Sponsor
Radboud University Medical Center (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05798065
Collaborator
(none)
3,700
1
3
1251.3

Study Details

Study Description

Brief Summary

Single center retrospective cohort study of all inpatient endoscopy procedures to asses factors associated with inpatient endoscopy delays and impact on length of stay and 30-day readmission

Condition or Disease Intervention/Treatment Phase
  • Procedure: Inpatient gastrointestinal endoscopy

Detailed Description

Background: Delays in inpatient endoscopy planning negatively influence the quality and accessibility of care. This may result in higher healthcare costs, negative health outcomes, and unnecessary readmissions and use of hospital beds. Additionally, prolonged hospital stay is associated with poorer health outcomes and risk of nosocomial infections, amongst others.

Objective: To asses factors associated with inpatient endoscopy delays and impact on length of stay and 30-day readmission

Study design: Single center retrospective cohort study of all inpatient endoscopy procedures (gastroscopy, colonoscopy, ERCP, sigmoidoscopy) during 2016-2022. Data will be identified and extracted using CTCue. Only pseudonymized data will be used. Inpatient endoscopy delay will be defined as the number of days between the planned date versus the actual date. Multivariable logistic regression models will be performed to assess factors associated with inpatient endoscopy delay.

Study Design

Study Type:
Observational
Anticipated Enrollment :
3700 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Inpatient Endoscopy Procedure Planning Delays and Impact on Length of Stay and 30-day Readmission
Anticipated Study Start Date :
Apr 1, 2023
Anticipated Primary Completion Date :
Jun 30, 2023
Anticipated Study Completion Date :
Jun 30, 2023

Outcome Measures

Primary Outcome Measures

  1. Rate of inpatient endoscopy delays (IED) [at endoscopic procedure]

    IED will be defined as the number of days between the planned date versus the actual date.

  2. Difference in type of endoscopic procedure between patients with and without IED [at endoscopic procedure]

    Type of endoscopic procedure: gastroscopy/colonoscopy/endoscopic retrograde cholangio-pancreaticography (ERCP)

  3. Difference in type of sedation between patients with and without IED [at endoscopic procedure]

    Type of sedation during endoscopic procedure: No sedation/conscious sedation/general anesthesia

Secondary Outcome Measures

  1. Median length of hospital stay [through study cohort period from 1 january 2016 until 31 december 2022]

    length of hospital admission in days

  2. rate of 30-day readmissions [up to 30 days]

    percentage of readmissions within 30 days after initial discharge

  3. Odds ratio of presence of inpatient endoscopy delays for risk of prolonged length of hospital stay and 30-day readmissions [from admission till 30 days after discharge]

    multivariable logistic regression modelling to assess factors associated with both outcomes and the impact of inpatient endoscopy delay

  4. Odds ratio of presence of inpatient endoscopy delays for risk of 30-day readmissions [from admission till 30 days after discharge]

    multivariable logistic regression modelling to assess factors associated with both outcomes and the impact of inpatient endoscopy delay

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Adult patients (>18 years)

  • Clinical admission in any hospital department of at least two days during 1 January 2016 and 1 December 2022

  • Endoscopic procedure during clinical admission, including gastroscopy, endoscopic retrograde cholangiopancreatography (ERCP), endoscopic ultrasound (EUS), flexible sigmoidoscopy, colonoscopy

Exclusion Criteria:
  • Elective admission

  • Procedure only for insertion of nasogastric or nasojejunal (feeding) tube without any other diagnostic or therapeutic aims

Contacts and Locations

Locations

Site City State Country Postal Code
1 Radboud university medical center Nijmegen Gelderland Netherlands 6525GA

Sponsors and Collaborators

  • Radboud University Medical Center

Investigators

  • Principal Investigator: Peter Siersema, MD, PhD, Radboud University Medical Center

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Radboud University Medical Center
ClinicalTrials.gov Identifier:
NCT05798065
Other Study ID Numbers:
  • 2023-16151
First Posted:
Apr 4, 2023
Last Update Posted:
Apr 4, 2023
Last Verified:
Jan 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Apr 4, 2023